InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,650.31
(
0.25%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 830
Posts 119741
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 14669

Thursday, 11/13/2008 11:26:04 PM

Thursday, November 13, 2008 11:26:04 PM

Post# of 19309
Index to Posts on PharmAthene

[Updated for 3Q08 financials and guidance
for reporting phase-1 Protexia results in 2Q09.]


#msg-33556075 3Q08 financial results
#msg-33140189 Phase-1 Protexia trial begins
#msg-27989353 Streamlined biodefense timeline

#msg-4107224 2004 IP license for Protexia
#msg-17826727 IP license expanded to all indications
#msg-22544066 2007 process and purification agreement
#msg-27957330 Extension of agreement through 2008

#msg-25964817 2008 Washington Post article
#msg-27925140 Protexia grant from US DoD
#msg-14110344 Protexia grant from NIH
#msg-28330311 Protexia program in Alzheimer’s disease
#msg-27806002 PharmAthene acquires biodefense vaccines

--
What are the economics of the relationship for GTC?

GTC has not disclosed the economic terms of the PharmAthene relationship; however, Dr. Cox did provide some color in reply to a question on GTC’s 4Q06 CC (#msg-17607391). Based on that, I think it’s conservative to assume that GTC stands to earn a mid-single-digit royalty on sales of Protexia. The PharmAthene relationship could thus generate a non-trivial income stream for GTC, especially if the Protexia program in Alzheimer’s disease were to pan out.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up